The market for obesity medications is growing rapidly; serious risks for people with eating disorders or disordered eating
CHICAGO, Sept. 10, 2025 /PRNewswire-PRWeb/ -- As the market for GLP-1 medications continues to expand rapidly, there are serious risks for individuals at risk of or currently experiencing eating disorders or disordered eating.
"There has been very little research done on the impact of taking GLP-1s in people with eating disorders," said Kim Dennis, MD, CEDS, CEO, and chief medical officer at SunCloud Health. "A few studies that have been conducted have shown mixed results, with some studies showing benefit to those with binge-type eating disorders and other studies not. Healthcare providers should be cautious and take an individualized approach when prescribing these medications. We need more research and greater collaboration among providers regarding the potential risks and benefits."
A recent Morgan Stanley Research report indicates the global market for GLP-1 medications will reach $150 billion annually by 2025. One reason is that the medications will be readily available in pill form.
While these medications can help reduce cardiovascular disease, type 2 diabetes, and related health issues, they also suppress reward circuitry and hunger signals, a mechanism in the brain that can be harmful to those vulnerable to disordered eating.
Other concerns for individuals with or at risk of eating disorders include:
- The negative impact on individuals with body image issues and weight stigma
- Malnourishment and nutrient deficiencies caused by appetite suppression
- Muscle and bone loss, dehydration, and metabolic shifts due to rapid weight loss
- Triggering restrictive eating patterns in individuals with current or past eating disorders
People with a history of bulimia, anorexia, or binge eating disorder will need closer monitoring, frequent check-ins, and collaboration among their treatment team.
"Family and friends can play an important role in supporting individuals at risk by listening without judgment, supporting size inclusivity, and taking the focus off of weight," adds Dr. Dennis.
About SunCloud Health:
SunCloud Health is an integrated, intensive outpatient, partial hospitalization (PHP), and residential treatment center with locations in Northbrook, Naperville, and Chicago (Lincoln Park). We provide highly individualized care, long-term support, and disease management for adults and adolescents of all genders experiencing alcohol and drug addiction, process addictions, eating disorders, mood disorders, post-traumatic stress disorder (PTSD), trauma, and other mental health conditions. Our integrated approach focuses on the unique history and needs of each patient, with an emphasis on helping those who are struggling with more than one co-occurring concern. We help our patients as they embark on a lifelong journey of recovery. For more information, visit www.suncloudhealth.com.
Media Contact
MaryAnne Morrow, SunCloud Health, 1 6023329026, [email protected], www.suncloudhealth.com
SOURCE SunCloud Health
Share this article